Drug intelligence / Profile preview

Qingyan Dripping Pills

Development stage
Unknown
Lead developer
Tianjin Pharmaceutical Da Ren Tang Group
Administration
Oral
01

Overview

Qingyan Dripping Pills (清咽滴丸) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited. It is specifically indicated for the treatment of various throat conditions, including acute and chronic pharyngitis, sore throat, dry throat, and red, swollen pharynx. The medication is produced using a specialized pharmaceutical technique where herbal extracts are thermally blended with excipients and solidified into droplets (dripping pills). Pharmacological research has identified key bioactive components such as borneol and menthol, which contribute to its anti-inflammatory and analgesic properties. During the COVID-19 pandemic, the formulation was recommended by the National Health Commission of the People's Republic of China for the symptomatic relief of throat-related issues, with studies suggesting potential anti-SARS-CoV-2 activity among its bioactive compounds.

Brand names
Qingyan Dripping Pills
Other names
清咽滴丸Qingyan Dripping WanQingyan Dropping Pills
02

Targets

PLpro (Papain-like protease)Mpro (3C-like proteinase of SARS-CoV-2)

Beyond the preview

Go deeper on Qingyan Dripping Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingyan Dripping Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call